EcoDrugPlus

Ensembl ID : WBGene00222517
Gene Symbol: WBGENE00222517
4 External references
29 Possible Orthologues:

Ensembl ID : WBGene00222538
Gene Symbol: WBGENE00222538
5 External references
416 Possible Orthologues:

Ensembl ID : WBGene00222561
Gene Symbol: WBGENE00222561
4 External references
89 Possible Orthologues:

Ensembl ID : WBGene00222581
Gene Symbol: WBGENE00222581
6 External references
206 Possible Orthologues:

Ensembl ID : WBGene00222582
Gene Symbol: WBGENE00222582
4 External references
84 Possible Orthologues:

Ensembl ID : WBGene00222602
Gene Symbol: WBGENE00222602
4 External references
751 Possible Orthologues:

Ensembl ID : WBGene00222608
Gene Symbol: WBGENE00222608
5 External references
342 Possible Orthologues:

Ensembl ID : WBGene00222621
Gene Symbol: WBGENE00222621
5 External references
1195 Possible Orthologues:

Ensembl ID : WBGene00222671
Gene Symbol: WBGENE00222671
6 External references
72 Possible Orthologues:

Ensembl ID : WBGene00222680
Gene Symbol: WBGENE00222680
3 External references
106 Possible Orthologues:

Ensembl ID : WBGene00222744
Gene Symbol: WBGENE00222744
6 External references
75 Possible Orthologues:

Ensembl ID : WBGene00220320
Gene Symbol: WBGENE00220320
3 External references
1193 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).